We are live on ! Find out more
SBRA icon

Sabra Healthcare REIT

335 hedge funds and large institutions have $3.85B invested in Sabra Healthcare REIT in 2018 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 120 increasing their positions, 103 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

148% more call options, than puts

Call options by funds: $6.65M | Put options by funds: $2.68M

21% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 39

17% more repeat investments, than reductions

Existing positions increased: 120 | Existing positions reduced: 103

8% more capital invested

Capital invested by funds: $3.55B → $3.85B (+$301M)

1.87% more ownership

Funds ownership: 91.51%93.38% (+1.9%)

2% more funds holding

Funds holding: 330335 (+5)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
335
Holders Change
+5
Holders Change %
+1.52%
% of All Funds
7.66%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
47
Increased
120
Reduced
103
Closed
39
Calls
$6.65M
Puts
$2.68M
Net Calls
+$3.97M
Net Calls Change
+$1.72M
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$28.6M +$489K +21,567 +2%
SFM
27
Systematic Financial Management
New Jersey
$27.9M +$9.83M +433,919 +56%
Wells Fargo
28
Wells Fargo
California
$26M -$937K -41,350 -4%
TA
29
Teachers Advisors
New York
$23.8M +$2.52M +111,336 +12%
Deutsche Bank
30
Deutsche Bank
Germany
$23M +$3.37M +148,901 +18%
Invesco
31
Invesco
Georgia
$22.5M +$314K +13,851 +1%
Millennium Management
32
Millennium Management
New York
$21M -$8.11M -357,956 -28%
Principal Financial Group
33
Principal Financial Group
Iowa
$18.3M +$194K +8,570 +1%
Morgan Stanley
34
Morgan Stanley
New York
$16.9M -$625K -27,603 -4%
Ameriprise
35
Ameriprise
Minnesota
$16.8M -$326K -14,377 -2%
TCM
36
Tekla Capital Management
Massachusetts
$16.8M
Legal & General Group
37
Legal & General Group
United Kingdom
$15.8M -$118K -5,225 -0.8%
Macquarie Group
38
Macquarie Group
Australia
$15.2M +$5.13M +226,604 +52%
HRES
39
Heitman Real Estate Securities
Illinois
$15.1M -$15.3M -675,342 -51%
SEI Investments
40
SEI Investments
Pennsylvania
$14.6M +$2.17M +95,747 +18%
Mirae Asset Global Investments
41
Mirae Asset Global Investments
South Korea
$14.1M +$13.8M +611,098 New
VRS
42
Virginia Retirement Systems
Virginia
$12.5M -$1.23M -54,500 -9%
UBS AM
43
UBS AM
Illinois
$12.3M +$490K +21,622 +4%
CM
44
Castleark Management
Illinois
$11.7M +$11.4M +504,000 New
Asset Management One
45
Asset Management One
Japan
$11.6M +$3.62M +159,888 +45%
FM
46
Forward Management
California
$11.6M -$12.8M -564,700 -53%
Two Sigma Investments
47
Two Sigma Investments
New York
$11.6M +$2.84M +125,136 +33%
AIG
48
American International Group
New York
$11M +$132K +5,814 +1%
AA
49
Ancora Advisors
Ohio
$10.8M +$1.18M +52,137 +13%
N
50
Nuveen
North Carolina
$10.5M -$10.4M -458,754 -50%

SBRA Hedge Fund Activity: Q3 2018 in Review

335 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Sabra Healthcare REIT (SBRA) for Q3 2018, worth a combined $3.85B — up 8.5% from $3.55B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new SBRA positions and 39 closed out — a net gain of 8 holders — while 120 added to existing stakes and 103 trimmed.

The largest buyer was Cohen & Steers, adding an estimated $107M. The largest seller was Citadel Advisors, cutting an estimated $30.8M.

  • 335 institutional investors held Sabra Healthcare REIT (SBRA) as of Q3 2018, up from 330 in Q2 2018.
  • Funds reported $3.85B of Sabra Healthcare REIT stock for Q3 2018, up 8.5% quarter-over-quarter.
  • 47 funds opened new Sabra Healthcare REIT positions in Q3 2018 and 39 closed out, a net change of +8 holders.
  • The largest Sabra Healthcare REIT buyer in Q3 2018 was Cohen & Steers, an estimated $107M added.
  • The largest Sabra Healthcare REIT seller in Q3 2018 was Citadel Advisors, an estimated $30.8M sold.

Based on aggregated 13F filings for Q3 2018.